Next Oncology

Houston, Texas 77054

5 studies enrolling now · 7 studies all time

What they study most

Advanced Breast Cancer, Advanced Cancer, Advanced Solid Tumor, Breast Cancer, Breast Cancer Metastatic, CCNE1 Amplification, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Locally Advanced (Unresectable) or Metastatic Solid Tumors, Metastatic Breast Cancer, Metastatic Cancer, Metastatic Solid Tumor

Studies at this site

• Phase 1/2 Study of UI-102 in Selected Advanced Cancers — Recruiting now
• A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors — Recruiting now
• A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors — Recruiting now
• Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer — Recruiting now
• A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors — Recruiting now
• Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer — Stopped early
• Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors — Running, not enrolling